Waffles sold at Dollarama recalled across Canada due to mold

Global NewsTuesday, October 21, 2025 at 7:27:43 PM
NegativeHealth
Waffles sold at Dollarama recalled across Canada due to mold
Health officials have issued a recall for waffle dessert items sold at Dollarama stores across Canada due to potential mold contamination. This is concerning as it highlights the importance of food safety and the need for consumers to be vigilant about the products they purchase. Mold can pose health risks, making it crucial for shoppers to check their items and stay informed.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
3 cases of new mpox strain reported in California
NeutralHealth
Health officials in Southern California are currently looking into three reported cases of a new strain of the Monkeypox virus. This investigation is crucial as it helps to monitor and control the spread of the virus, ensuring public safety and health awareness in the region.
Foreign outbreaks, lower vaccination rates are troubling signs for California's coming flu season
NegativeHealth
California is bracing for a potentially severe flu season, with health officials expressing concerns over foreign outbreaks and declining vaccination rates. Last year's flu season was particularly harsh, and the current indicators suggest that this year could mirror those challenges. It's crucial for residents to stay informed and consider getting vaccinated to protect themselves and their communities.
Latest from Health
During cold and flu season, the youngest kids really are the germiest
NeutralHealth
A recent study has revealed that the youngest schoolchildren tend to carry the most germs during the cold and flu season. This finding is significant as it highlights the importance of hygiene practices in schools to prevent the spread of illnesses among children, who are often more susceptible to infections. Understanding the germ patterns in younger students can help parents and educators implement better health measures.
NHS trusts dropped from maternity failings review
NeutralHealth
The Shropshire and Leeds NHS trusts have been removed from a rapid review concerning maternity failings in England. This decision affects two of the fourteen trusts initially included in the review, which aims to address concerns about maternity care. The implications of this change could influence how maternity services are evaluated and improved in the future.
During cold and flu season, the youngest kids really are the germiest
NeutralHealth
As the cold and flu season approaches, caregivers are reminded that young children are often the most susceptible to germs, leading to increased coughs, sneezes, and sniffles. This highlights the importance of taking preventive measures to protect their health and the health of those around them.
Workers and Employers Face Higher Health Insurance Costs
NegativeHealth
A recent employer survey reveals that health insurance premiums for families are set to rise in 2025, placing a heavier financial burden on both companies and their employees. This increase is significant as it highlights the ongoing challenges in the healthcare system, affecting affordability and access to necessary medical services. As costs continue to climb, it raises concerns about the overall well-being of workers and the sustainability of employer-sponsored health plans.
China’s Innovent Strikes Cancer Drug Deal With Takeda for Up to $11.4 Billion
PositiveHealth
China's Innovent has made a significant move by partnering with Takeda in a deal worth up to $11.4 billion for a cancer drug. This collaboration highlights the growing trend of Chinese companies joining forces with international pharmaceutical giants to enhance their global presence and leverage the innovative drug development happening in China. Such partnerships not only boost the companies involved but also promise to bring new treatment options to patients worldwide.
Thermo Scientific Revenue Rises, Boosted by Life Sciences Business
PositiveHealth
Thermo Scientific has reported a significant rise in revenue, with third-quarter sales reaching $11.12 billion, largely driven by growth in its life sciences sector. This is important as it highlights the company's strong performance and the increasing demand for scientific services, which could lead to further investments and innovations in the field.